AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 160 filers reported holding AKERO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,692 | +93740.0% | 200 | 0.0% | 0.00% | – |
| Q1 2024 | $5 | -89.1% | 200 | -90.0% | 0.00% | – |
| Q4 2023 | $46 | -8.0% | 2,000 | +100.0% | 0.00% | – |
| Q3 2023 | $50 | +177.8% | 1,000 | +150.0% | 0.00% | – |
| Q2 2023 | $18 | -100.0% | 400 | -84.6% | 0.00% | – |
| Q4 2020 | $67,000 | -16.2% | 2,600 | 0.0% | 0.00% | – |
| Q3 2020 | $80,000 | +63.3% | 2,600 | +30.0% | 0.00% | – |
| Q2 2020 | $49,000 | +81.5% | 2,000 | +53.8% | 0.00% | – |
| Q1 2020 | $27,000 | -3.6% | 1,300 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -51.7% | 1,300 | -50.0% | 0.00% | – |
| Q3 2019 | $58,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |